Featured Genomics & ncRNA Research Solutions
The Dawn of Non-Coding RNA Sequencing in Chad
Non-coding RNA (ncRNA) sequencing has emerged as one of the most transformative frontiers in modern molecular biology. Historically dismissed as "junk DNA," non-coding RNAs—including long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs)—are now recognized as master regulators of gene expression. They play vital roles in cellular processes, disease progression, immune responses, and environmental stress adaptation. In the Republic of Chad, the application of this cutting-edge genomic technology is unlocking unprecedented opportunities across agriculture, veterinary medicine, environmental conservation, and public health.
As Chad seeks to diversify its economy and strengthen its scientific research capabilities, local institutions in N'Djamena and other academic hubs are increasingly looking toward advanced biotechnology. The Chadian scientific community, supported by international partnerships, is recognizing the power of high-throughput transcriptomics to address local challenges. By analyzing the complex regulatory networks of non-coding RNAs, researchers can gain deep insights into how native species adapt to the arid Sahelian climate, how local livestock breeds resist endemic diseases, and how human pathogens interact with host immune systems.
Sahelian Crop Resilience
Utilizing ncRNA sequencing to identify key regulatory pathways in local crops like cotton, millet, and sorghum to design drought-resistant strains.
Livestock Health & Adaptation
Investigating molecular biomarkers in Chadian cattle breeds to enhance resistance against endemic parasites and severe thermal stress.
Public Health Breakthroughs
Decoding host-pathogen interactions at the non-coding RNA level to accelerate diagnostic and therapeutic research for infectious diseases.
Localized Application Scenarios & Biotech Trends in Chad
The commercial and industrial landscape for genomic technologies in Central Africa is expanding rapidly. In Chad, agricultural development and public health represent the two main pillars of genomic application. Organizations such as the Chadian Institute for Agricultural Research for Development (ITRAD) and local universities are focused on improving crop yields and food security. Non-coding RNA sequencing offers a direct pathway to understanding epigenetic regulation in plants under environmental stress, providing critical data for breeding programs aimed at combating desertification and soil salinity.
Furthermore, Chad's livestock sector is a major economic driver. The health of Zebu cattle, sheep, and goats is paramount. By applying transcriptomic profiling, veterinarians and researchers can pinpoint how non-coding RNAs modulate the immune response during infections like bovine tuberculosis or trypanosomiasis. This localized research is vital for developing targeted vaccines and breeding strategies tailored specifically to the biological profiles of Chadian livestock.
On the public health front, the tracking and characterization of infectious diseases like malaria and viral fevers in Chad benefit immensely from transcriptomics. Understanding how human host microRNAs change in response to infection helps identify novel biomarkers for early diagnosis and therapeutic targets, ultimately reducing the burden on Chad's healthcare infrastructure.
Biomarker Technologies (BMKGene)
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Leading, Multi-Level High-Throughput Sequencing Platforms
Advanced Sequencing Systems
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system
Waters XEVO G2-XS QTOF
QTRAP 6500+
Over 20,000 Square Feet Place
Advanced biomolecular laboratory instruments.
Standard labs of sample extraction, library construction, clean rooms, and sequencing labs.
Standard procedures from sample extraction to sequencing under strict SOPs.
BMKCloud Bioinformatic Platform
Reliable, easy-to-use on-line bioinformatic analysis platform.
Self-developed BMKCloud platform.
CPUs with 41,104 memory and 3 PB total storage.
4,260 computing cores with peak computing power over 121,708.8 Gflop per second.
Next-Generation Automation in Sequencing Services
Fully Automated Platform for Next-generation sequencing--Brilliant Lab 1000
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services worldwide, including researchers in Chad and Central Africa.
Enterprise Qualifications & Scientific Patents
Our commitment to quality and innovation is backed by global certifications, national workstations, and a robust portfolio of proprietary patents.
![[Copy] Eukaryotic mRNA Sequencing-NGS](http://www.bmkgene.com/uploads/%E7%BD%91%E7%AB%99%E4%BA%A7%E5%93%8125.1.14-033.jpg)
